COVID‐19 vaccine hesitancy: The synergistic effect of anxiety and proactive coping

Abstract Background This study sought to identify cognitive and behavioral predictors of COVID‐19 vaccine hesitancy. Specifically, this study examined the effect of anxiety about developing COVID‐19 and proactive coping behavior on the likelihood of reporting COVID‐19 vaccine hesitancy in a sample o...

Full description

Saved in:
Bibliographic Details
Main Authors: MacKenzie L. Hughes (Author), Shevaun D. Neupert (Author), Emily L. Smith (Author), Clara W. Coblenz (Author), Samuel G. Macy (Author), Ann Pearman (Author)
Format: Book
Published: Wiley, 2023-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a9fd1a3f2f044e5a83ed0e92bc32ffa7
042 |a dc 
100 1 0 |a MacKenzie L. Hughes  |e author 
700 1 0 |a Shevaun D. Neupert  |e author 
700 1 0 |a Emily L. Smith  |e author 
700 1 0 |a Clara W. Coblenz  |e author 
700 1 0 |a Samuel G. Macy  |e author 
700 1 0 |a Ann Pearman  |e author 
245 0 0 |a COVID‐19 vaccine hesitancy: The synergistic effect of anxiety and proactive coping 
260 |b Wiley,   |c 2023-03-01T00:00:00Z. 
500 |a 2769-2450 
500 |a 10.1002/puh2.70 
520 |a Abstract Background This study sought to identify cognitive and behavioral predictors of COVID‐19 vaccine hesitancy. Specifically, this study examined the effect of anxiety about developing COVID‐19 and proactive coping behavior on the likelihood of reporting COVID‐19 vaccine hesitancy in a sample of adults living in the United States. Methods An online survey of proactive coping strategies, anxiety related to developing COVID‐19, and vaccine hesitancy was administered in October 2020 to 534 adults aged 21-79‐years old. Age, gender, race, self‐rated health, years of education, COVID‐19 knowledge, and perceived constraints were included as covariates. Results Over half of the study participants (56.7%) were COVID‐19 vaccine hesitant. People who were less anxious about developing COVID‐19 were more likely to be vaccine hesitant. A statistically significant COVID‐19 anxiety × proactive coping interaction showed the odds of vaccine hesitancy was highest among individuals with low anxiety about developing COVID‐19 and high proactive coping, whereas vaccine hesitancy was lowest among individuals with high COVID‐19 anxiety and high proactive coping. Conclusion Results support a future‐oriented approach to public health outreach efforts regarding COVID‐19 vaccines. Improvement of proactive coping skills and emphasis on the likelihood of contracting COVID‐19 may be more effective in increasing vaccine uptake than simply restating scientific facts regarding safety or efficacy. 
546 |a EN 
690 |a anxiety 
690 |a COVID‐19 
690 |a pandemic 
690 |a proactive coping 
690 |a vaccination attitudes 
690 |a vaccine hesitancy 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Public Health Challenges, Vol 2, Iss 1, Pp n/a-n/a (2023) 
787 0 |n https://doi.org/10.1002/puh2.70 
787 0 |n https://doaj.org/toc/2769-2450 
856 4 1 |u https://doaj.org/article/a9fd1a3f2f044e5a83ed0e92bc32ffa7  |z Connect to this object online.